First US Companies List a CRISPR Trial, for Blood Conditions First US Companies List a CRISPR Trial, for Blood Conditions

Two US companies registered a CRISPR-based treatment for β -thalassemia at ClinicalTrials.gov.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news